Key facts
- Hone Health’s last known valuation is $312.8M (Jan 2025).
- It has raised $48.5M; the latest was Later Stage VC ($32.8M) in Jan 2025.
- Notable investors include FJ Labs, Gaingels, Calm Ventures, Tribe Capital, Makai VC — 31 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 31 names
- ·Watchlist + deal alerts for Hone Health
- ·The full record, as it builds
Funding rounds
No funding rounds for Hone Health are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Hone Health
Developer of a telemedicine kit designed to help men and women lead longer, healthier lives. The company offers consulting services for anti-aging treatments and allows users to monitor their blood with the help of professional doctors through its FDA-approved testing system to book personalized treatment, enabling consumers to track their hormonal changes to get them treated affordably.
- Sector
- Healthcare
- HQ
- New York, NY, United States
- Founded
- 2020
- Employees
- 100
- Website
- honehealth.com/
- Ownership
- Privately Held (backing)
Hone Health doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Hone Health shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Hone Health in its N-PORT filings yet. We sweep new filings monthly.